title: Cutaneous tuberculosis and pyoderma gangrenosum.
authors.affiliation: Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, and Department of Dermatology, Osaka Red Cross Hospital, Osaka, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Matsui
authors.forename: E
authors.initials: E
authors.lastname: Ohtoshi
authors.forename: J
authors.initials: J
authors.lastname: Yamaoka
authors.forename: N
authors.initials: N
authors.lastname: Matsuyoshi
authors.forename: K
authors.initials: K
authors.lastname: Ohta
authors.forename: K
authors.initials: K
authors.lastname: Toda
authors.forename: Y
authors.initials: Y
authors.lastname: Horiguchi
authors.forename: S
authors.initials: S
authors.lastname: Imamura
mesh_terms: D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D005533:Foot Dermatoses / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications*; D017511:Pyoderma Gangrenosum / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D012293:Rifampin / Q000627:therapeutic use; D014382:Tuberculosis, Cutaneous / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology
chemical_list: D000904:Antibiotics, Antitubercular; D007538:Isoniazid; D012293:Rifampin